First human trial of QX-4533 begins safety testing
Knowledge-focused
Not yet recruiting
This phase 1 trial tests the safety and tolerability of a new drug called QX-4533 in 90 healthy adults aged 18 to 55. Participants receive either single or multiple doses of the drug or a placebo, and the study also looks at how food affects the drug's levels in the body. The goa…
Phase: PHASE1 • Sponsor: QuantX Biosciences, Inc. • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC